Saroja Pharma Industries India Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Saroja Pharma Industries India has been growing earnings at an average annual rate of 18.5%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 0.2% per year. Saroja Pharma Industries India's return on equity is 6%, and it has net margins of 2.2%.
Belangrijke informatie
18.5%
Groei van de winst
-38.2%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 29.4% |
| Inkomstengroei | 0.2% |
| Rendement op eigen vermogen | 6.0% |
| Nettomarge | 2.2% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Saroja Pharma Industries India geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 407 | 9 | 16 | 0 |
| 31 Dec 23 | 427 | 9 | 16 | 0 |
| 30 Sep 23 | 448 | 10 | 16 | 0 |
| 30 Jun 23 | 475 | 10 | 16 | 0 |
| 31 Mar 23 | 502 | 11 | 16 | 0 |
| 31 Mar 22 | 556 | 11 | 13 | 0 |
| 31 Mar 21 | 367 | 7 | 10 | 0 |
| 31 Mar 20 | 171 | 2 | 8 | 0 |
Kwaliteitswinsten: SAROJA has a high level of non-cash earnings.
Groeiende winstmarge: SAROJA's current net profit margins (2.2%) are higher than last year (2.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SAROJA's earnings have grown by 18.5% per year over the past 5 years.
Versnelling van de groei: SAROJA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: SAROJA had negative earnings growth (-17.2%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Rendement op eigen vermogen
Hoge ROE: SAROJA's Return on Equity (6%) is considered low.